Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nervous System Malformations | 2 | 2021 | 243 | 0.840 |
Why?
|
| Obesity, Morbid | 6 | 2019 | 1298 | 0.840 |
Why?
|
| Stomach | 4 | 2019 | 701 | 0.780 |
Why?
|
| Bariatric Surgery | 4 | 2015 | 1001 | 0.720 |
Why?
|
| Fetal Diseases | 2 | 2021 | 916 | 0.660 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2021 | 587 | 0.660 |
Why?
|
| Risperidone | 3 | 2017 | 383 | 0.620 |
Why?
|
| Laparoscopy | 5 | 2019 | 2041 | 0.570 |
Why?
|
| Islam | 1 | 2015 | 72 | 0.480 |
Why?
|
| Weight Loss | 4 | 2019 | 2721 | 0.480 |
Why?
|
| Hunger | 1 | 2015 | 207 | 0.450 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 461 | 0.380 |
Why?
|
| Antidepressive Agents | 4 | 2016 | 2913 | 0.360 |
Why?
|
| Minocycline | 3 | 2016 | 170 | 0.360 |
Why?
|
| Lysine | 1 | 2014 | 1000 | 0.340 |
Why?
|
| Fasting | 1 | 2015 | 1610 | 0.330 |
Why?
|
| Fluvoxamine | 2 | 2016 | 78 | 0.270 |
Why?
|
| Riluzole | 2 | 2016 | 62 | 0.260 |
Why?
|
| Antipsychotic Agents | 2 | 2016 | 3081 | 0.230 |
Why?
|
| Bipolar Disorder | 3 | 2017 | 5130 | 0.220 |
Why?
|
| Double-Blind Method | 12 | 2017 | 12465 | 0.210 |
Why?
|
| Abdominal Wall | 1 | 2021 | 166 | 0.170 |
Why?
|
| Neuroprotective Agents | 2 | 2016 | 958 | 0.160 |
Why?
|
| Depression | 5 | 2016 | 8230 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2019 | 234 | 0.150 |
Why?
|
| Gastric Bypass | 2 | 2019 | 824 | 0.150 |
Why?
|
| Prenatal Diagnosis | 2 | 2021 | 1275 | 0.150 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2016 | 1508 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2021 | 1772 | 0.140 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2015 | 319 | 0.130 |
Why?
|
| Esophagus | 1 | 2021 | 1042 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2014 | 6983 | 0.130 |
Why?
|
| Fissure in Ano | 1 | 2015 | 14 | 0.120 |
Why?
|
| Kidney Cortex | 1 | 2015 | 168 | 0.120 |
Why?
|
| Diclofenac | 1 | 2015 | 69 | 0.120 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 463 | 0.120 |
Why?
|
| Radiology Information Systems | 1 | 2019 | 533 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2015 | 89 | 0.120 |
Why?
|
| Diltiazem | 1 | 2015 | 132 | 0.120 |
Why?
|
| Acetamides | 1 | 2016 | 259 | 0.120 |
Why?
|
| Iran | 2 | 2015 | 763 | 0.120 |
Why?
|
| Workflow | 1 | 2019 | 860 | 0.120 |
Why?
|
| Abdomen | 1 | 2020 | 1136 | 0.120 |
Why?
|
| Lithium | 1 | 2017 | 600 | 0.110 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2016 | 451 | 0.110 |
Why?
|
| Colon | 1 | 2021 | 1801 | 0.110 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2015 | 361 | 0.110 |
Why?
|
| Colostomy | 1 | 2013 | 106 | 0.110 |
Why?
|
| Enema | 1 | 2013 | 141 | 0.110 |
Why?
|
| Neuromuscular Agents | 1 | 2015 | 148 | 0.110 |
Why?
|
| Gastroplasty | 1 | 2015 | 159 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 7477 | 0.110 |
Why?
|
| Citalopram | 1 | 2016 | 401 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2016 | 6029 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 394 | 0.100 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 491 | 0.100 |
Why?
|
| Valproic Acid | 1 | 2015 | 444 | 0.100 |
Why?
|
| Simvastatin | 1 | 2015 | 346 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2017 | 942 | 0.100 |
Why?
|
| Treatment Outcome | 13 | 2017 | 65371 | 0.100 |
Why?
|
| Durapatite | 1 | 2014 | 167 | 0.100 |
Why?
|
| Female | 29 | 2021 | 397192 | 0.100 |
Why?
|
| Kidney Pelvis | 1 | 2013 | 191 | 0.100 |
Why?
|
| Anal Canal | 1 | 2015 | 376 | 0.100 |
Why?
|
| Methylphenidate | 1 | 2016 | 480 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2014 | 570 | 0.100 |
Why?
|
| Drug Therapy, Combination | 6 | 2017 | 6316 | 0.100 |
Why?
|
| Ureteral Obstruction | 1 | 2013 | 293 | 0.100 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 549 | 0.090 |
Why?
|
| Renal Replacement Therapy | 1 | 2013 | 282 | 0.090 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2015 | 238 | 0.090 |
Why?
|
| Ureter | 1 | 2013 | 364 | 0.090 |
Why?
|
| Male | 26 | 2019 | 364719 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 990 | 0.090 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2014 | 433 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 863 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2015 | 583 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 594 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2019 | 15832 | 0.080 |
Why?
|
| Gastrectomy | 1 | 2014 | 693 | 0.080 |
Why?
|
| Device Removal | 1 | 2013 | 643 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 39348 | 0.080 |
Why?
|
| Reoperation | 1 | 2019 | 4329 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1039 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1191 | 0.070 |
Why?
|
| Iron | 1 | 2016 | 1813 | 0.070 |
Why?
|
| Humans | 31 | 2021 | 768166 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4860 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2016 | 1240 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2015 | 2191 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 9015 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 8542 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 1702 | 0.060 |
Why?
|
| Liver | 2 | 2021 | 7577 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3533 | 0.060 |
Why?
|
| Young Adult | 7 | 2016 | 60066 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2021 | 26422 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3857 | 0.060 |
Why?
|
| Adult | 14 | 2019 | 223646 | 0.060 |
Why?
|
| Endoscopy | 1 | 2014 | 1854 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2017 | 6412 | 0.050 |
Why?
|
| Oxygen | 1 | 2015 | 4270 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 30256 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2015 | 1713 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2015 | 9384 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 1942 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2015 | 13053 | 0.050 |
Why?
|
| Linear Models | 3 | 2016 | 5884 | 0.050 |
Why?
|
| Stents | 1 | 2013 | 3195 | 0.050 |
Why?
|
| Developing Countries | 1 | 2014 | 2910 | 0.050 |
Why?
|
| Adolescent | 8 | 2017 | 89169 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2496 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 3729 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2019 | 54926 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3251 | 0.040 |
Why?
|
| Child | 7 | 2017 | 80917 | 0.040 |
Why?
|
| Jejunoileal Bypass | 1 | 2019 | 13 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 36743 | 0.040 |
Why?
|
| Middle Aged | 11 | 2019 | 223492 | 0.040 |
Why?
|
| Organs at Risk | 1 | 2020 | 367 | 0.040 |
Why?
|
| Malabsorption Syndromes | 1 | 2019 | 135 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4818 | 0.040 |
Why?
|
| Age Factors | 1 | 2014 | 18412 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2017 | 317 | 0.030 |
Why?
|
| Pelvis | 1 | 2020 | 736 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 10873 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2014 | 24315 | 0.030 |
Why?
|
| Immunocompetence | 1 | 2015 | 138 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2016 | 41754 | 0.030 |
Why?
|
| Irritable Mood | 1 | 2016 | 196 | 0.030 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2015 | 238 | 0.030 |
Why?
|
| Renal Circulation | 1 | 2015 | 291 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 13090 | 0.030 |
Why?
|
| Ferritins | 1 | 2016 | 601 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2014 | 130 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 556 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 15948 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Antimanic Agents | 1 | 2017 | 524 | 0.030 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 404 | 0.030 |
Why?
|
| Hyperoxia | 1 | 2015 | 261 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2015 | 703 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 684 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 2661 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 2015 | 830 | 0.030 |
Why?
|
| Hematuria | 1 | 2013 | 232 | 0.030 |
Why?
|
| Aged | 5 | 2016 | 171504 | 0.020 |
Why?
|
| Fecal Incontinence | 1 | 2015 | 246 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2016 | 1760 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 21206 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 625 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2013 | 436 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2015 | 1888 | 0.020 |
Why?
|
| Random Allocation | 1 | 2015 | 2396 | 0.020 |
Why?
|
| Forecasting | 1 | 2019 | 2945 | 0.020 |
Why?
|
| Microcirculation | 1 | 2015 | 1281 | 0.020 |
Why?
|
| Medical Records | 1 | 2015 | 1410 | 0.020 |
Why?
|
| Reference Values | 1 | 2017 | 4938 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 2862 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 17569 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 1967 | 0.020 |
Why?
|
| Analgesics | 1 | 2015 | 1071 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2016 | 42669 | 0.020 |
Why?
|
| Infant | 3 | 2015 | 36535 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2016 | 1168 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 804 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2016 | 2204 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2149 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2016 | 1107 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 2360 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6498 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 2665 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2015 | 3139 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4362 | 0.010 |
Why?
|
| Time Factors | 2 | 2013 | 40218 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10632 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12800 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14729 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 23760 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14164 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15869 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 81762 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20760 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18349 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 26379 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 13490 | 0.010 |
Why?
|
| United States | 1 | 2019 | 73039 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 74944 | 0.000 |
Why?
|
| Animals | 1 | 2015 | 169246 | 0.000 |
Why?
|
Concepts
(189)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_